PBlue adventures

Moderna: Selling to Zero

pBlue
Publish date: Fri, 20 Nov 2020, 01:58 AM
pBlue
0 21
PBlue a buy and hold investor and occasional swing trader on the side.

"On a scale of one to 10, one being less concerned and 10 being the most concerned," said Daniel Taylor, an associate professor of accounting at the Wharton School, "this is an 11."

[It is legal] "But the optics aren't great." said Marc Fagel, a former enforcement official with the Securities And Exchange Commission (SEC)

 

Moderna's execs seem to behave rather strangely. For a company with a product that is of great demand, could earn tens of billions of dollars, and push share prices to even greather heights, its execs are very eager to sell all their stock in their company.

 

CEO Stéphane Bancel (Sold 60% of his stock)

Chief Medical Officer Dr. Tal Zaks, (Sold all stock)

Chief Financial Officer Lorence H. Kim. (left in August 2020) (Sold all stock)

Chief Technical Operations and Quality Officer Juan Andres (Sold all stock)

General Counsel Lori Henderson (sold nearly all her stock)

 

This is very worrying behavior, especially as the CEO and Chief Medical Officer would be the best informed on the status of their company's first and only product, the Covid19 vaccine. Why then we must ask, do they sell to Zero?

In fact this is the kind of behavior you would expect from people who are abandoning ship. People who are selling all their shares while it is still worth something. So for all the enthusiasm the public has shown for Moderna, be aware their execs have cashed out early and have sold all their shares.

 

https://www.npr.org/2020/09/04/908305074/bad-optics-or-something-more-moderna-executives-stock-sales-raise-concerns

Discussions
2 people like this. Showing 1 of 1 comments

wkc5657

these execs sold their current holdings, not vested holdings through conditional stock options.....

these options are many times more than their yearly salary...

2020-11-20 11:03

Post a Comment